It’s All in the Head: Updates in Neuropsychiatric Pharmacotherapy in the Big and Small

• Series Overview
• Program Content
• Faculty
• Target Audience and Learning Objectives
• Continuing Pharmacy Education Credit
• BCPS and BCPPS Specialty Recertification Credit
• Technical Requirements
• Commercial Support
• Fees

Clinical Reasoning Series in Pharmacotherapy has been approved by the Board of Pharmacy Specialties for recertification of Board Certified Pharmacotherapy Specialists (BCPSs) and for recertification of Board Certified Pediatric Pharmacy Specialists (BCPPSs).

Both BCPSs and BCPPSs are involved in the management of patients affected by substance abuse, particularly opioids and alcohol. These specialists are often responsible for the provision of services in both the inpatient and outpatient settings where they develop and monitor drug therapy regimens for the acute and chronic sequela of substance abuse. Headache, too, is a common and often underappreciated condition in adult and pediatric populations. As new treatment modalities are identified to treat headache and migraine, BCPSs and BCPPSs must be able to identify evidence-based strategies to manage these conditions. Given the prevalence of substance abuse and headache, the impact of these conditions on patient quality of life, and the complexity of managing these conditions in special populations, this program will address current evidence-based strategies and summarize their place in contemporary patient care. The program will consist of two educational activities: one addressing substance abuse, the second addressing headache/migraine.

Release date: November 25, 2019
ORIGINAL BCPS and BCPPS credit expiration date: May 15, 2020
EXTENDED BCPS and BCPPS credit expiration date: July 10, 2020
ACPE credit expiration date: November 14, 2022

Topics to be covered include the management of patients affected by substance abuse, particularly opioids and alcohol. Each activity will discuss treatment strategies in adults and provide guidance on the management of pediatric, adolescent, and peripartum patients.

	Robert Helmer, Pharm.D. Assistant Clinical Professor of Pharmacy Practice Auburn University Harrison School of Pharmacy Mobile, Alabama
	Cherry W. Jackson, Pharm.D., FASHP, FCCP, BCPP Clinical Professor of Psychiatry and Behavioral Neurobiology Auburn University Harrison School of Pharmacy Auburn, Alabama
	Melissa C. Palmer, Pharm.D., BCPS, BCPP Clinical Assistant Professor University of Missouri-Kansas City (UMKC) School of Pharmacy Kansas City, Missouri
	Kimberly B. Tallian, Pharm.D., FCCP, BCPP Advanced Practice Pharmacist - Psychiatry Scripps Mercy Hospital San Diego, California
	Kristine Parbuoni, Pharm.D., BCPPS Associate Professor University of Maryland School of Pharmacy Baltimore, Maryland

Clinical Pharmacists, BCPSs and BCPPSs providing care to patients with substance abuse, particularly opioids and alcohol and addressing headaches/migraines. Each activity will discuss treatment strategies in adults and provide guidance on the management of pediatric, adolescent, and peripartum patients.

At the conclusion of Part 1 of the program, the participant should be able to:

• Identify adult and pediatric patients at risk for complications from substance abuse
• Determine the best therapeutic option(s) in managing acute and chronic alcohol or opioid abuse in adult, adolescent, and peripartum patients
• Apply clinical evidence to the management of neonatal abstinence syndrome

At the conclusion of Part 2 of the program, the participant should be able to:

• Discuss emerging therapeutic options in the management of migraine headaches in adults
• Determine the best therapeutic options(s) in managing an adult or pediatric patient with acute or chronic headache
• Apply clinical data to individual patient care and formulary decisions regarding drugs used for headache in adult and pediatric patients

The American College of Clinical Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

It’s All in the Head: Updates in Neuropsychiatric Pharmacotherapy in the Big and Small Part 1

It’s All in the Head: Updates in Neuropsychiatric Pharmacotherapy in the Big and Small Part 2

Methods and CE Requirements

ACPE Continuing Pharmacy Education Credit
To be eligible to earn ACPE continuing pharmacy education (CPE) credit, participants must purchase and successfully complete the course, and submit and pass the Web-based posttest(s) by November 14, 2022. Partial credit is not available for this activity. Posttests may not be submitted more than one time.

National Association of Boards of Pharmacy - CPE Monitor Service

Provided through the collaborative efforts of the National Association of Boards of Pharmacy (NABP), the Accreditation Council for Pharmacy Education (ACPE), and ACPE-accredited providers, the CPE Monitor Service allows you to electronically keep track of continuing pharmacy education (CPE) credits from ACPE-accredited providers. ACPE-accredited providers, like ACCP, are responsible for transmitting this information to NABP to be stored in the CPE Monitor system. Statements of credit will be available at CPE Monitor, nabp.pharmacy/cpe-monitor-service/, within 2–3 business days after completion of this activity. For more information on CPE Monitor please visit nabp.pharmacy/cpe-monitor-service/.

To transfer these credits to CPE Monitor on your behalf your NABP e-Profile ID Number and date of birth must be listed on your ACCP account. To verify or update this information in your ACCP account, visit Licensure/Certification. Be sure to save your changes at the bottom of the page.

Some international pharmacists do not use the CPE Monitor service. To verify or update this information in your ACCP account, visit Licensure/Certification. Check the box “I am an international pharmacist or I am not licensed to practice in the United States, and do not have an NABP e-Profile ID.” Be sure to save your changes at the bottom of the page.

 

To be eligible to earn recertification credit, BCPSs and BCPPSs must purchase the recertification version of this course, successfully complete the course, and submit and pass the web-based posttest associated with each module by July 10, 2020. Partial credit is not available for this activity. Posttests may not be submitted more than one time.

The passing point to earn BCPS and BCPPS recertification credit is based on an expert analysis of the assessment items in each posttest module. Any posttest submitted before the BCPS and BCPPS posttest deadline that meets this passing point will earn BCPS and BCPPS recertification credits. These credits will be assigned as of the date of test submission and reported within 48 hours to BPS. For statements of recertification credit, visit www.bpsweb.org.

All participants must have a Board of Pharmacy Specialties (BPS) board certification credential number, BPS ID Number, and a BPS expiration date on file with ACCP for reporting purposes. To verify or update this information in your ACCP account, visit Licensure/Certification. Be sure to save your changes at the bottom of the page.

Questions regarding the number of hours required for BCPS and BCPPS recertification should be directed to BPS at (202) 429-7591 or www.bpsweb.org. The ACCP Recertification Dashboard is a free online tool that can track recertification credits as they are earned through ACCP and schedule new opportunities for credits from upcoming ACCP professional development programs.

Requires an Internet browser and Adobe Reader.

The American College of Clinical Pharmacy does not solicit or accept external commercial/financial support for its continuing pharmacy education activities. No commercial/financial support has been solicited or accepted for this activity.